ATE377654T1 - Ubiquitin-ligase-assay - Google Patents

Ubiquitin-ligase-assay

Info

Publication number
ATE377654T1
ATE377654T1 AT01924655T AT01924655T ATE377654T1 AT E377654 T1 ATE377654 T1 AT E377654T1 AT 01924655 T AT01924655 T AT 01924655T AT 01924655 T AT01924655 T AT 01924655T AT E377654 T1 ATE377654 T1 AT E377654T1
Authority
AT
Austria
Prior art keywords
ubiquitin ligase
ligase assay
assay
assays
relates
Prior art date
Application number
AT01924655T
Other languages
English (en)
Inventor
Sarkiz Issakani
Jianing Huang
Julie Sheung
Todd Pray
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE377654T1 publication Critical patent/ATE377654T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/9015—Ligases (6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
AT01924655T 2000-04-03 2001-04-03 Ubiquitin-ligase-assay ATE377654T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/542,497 US6740495B1 (en) 2000-04-03 2000-04-03 Ubiquitin ligase assay

Publications (1)

Publication Number Publication Date
ATE377654T1 true ATE377654T1 (de) 2007-11-15

Family

ID=24164065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01924655T ATE377654T1 (de) 2000-04-03 2001-04-03 Ubiquitin-ligase-assay

Country Status (9)

Country Link
US (5) US6740495B1 (de)
EP (1) EP1268847B1 (de)
JP (1) JP4095805B2 (de)
AT (1) ATE377654T1 (de)
AU (1) AU2001251291A1 (de)
DE (1) DE60131262T2 (de)
DK (1) DK1268847T3 (de)
ES (1) ES2296744T3 (de)
WO (1) WO2001075145A2 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378248B2 (en) * 2000-03-06 2008-05-27 Rigel Pharmaceuticals, Inc. In vivo production of cyclic peptides for inhibiting protein-protein interaction
US6979551B2 (en) * 2000-04-03 2005-12-27 Rigel Pharmaceuticals, Inc. Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
US6740495B1 (en) * 2000-04-03 2004-05-25 Rigel Pharmaceuticals, Inc. Ubiquitin ligase assay
US20020028472A1 (en) * 2000-06-29 2002-03-07 Michael Gmachl Methods for identifying inhibitors of the anaphase promoting complex
DE10108263A1 (de) * 2001-02-21 2002-09-05 Max Planck Gesellschaft Analyse von Modifizierungen und Demodifizierungen von Proteinen mit Ubiquitinverwandten Proteinen mittels FRET (Fluorescence Resonance Energy Transfer)
DE60235996D1 (de) 2001-09-07 2010-05-27 Takeda Pharmaceutical Diagnostische und therapeutische verwendung von f-box-proteinen bei morbus alzheimer und verwandten neurodegenerativen erkrankungen
IL162062A0 (en) * 2001-11-19 2005-11-20 Proteologics Inc Methods for identifying and validating potential drug targets
EP1867731A3 (de) 2002-08-30 2008-03-12 Rigel Pharmaceuticals, Inc. Verfahren zum Testen von Modulatoren von Entzündungsprozessen über Teile der Ubiquitinbindungskaskade
US7736846B2 (en) * 2002-08-30 2010-06-15 Rigel Pharmaceuticals, Inc. Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade
US7723018B2 (en) 2002-08-30 2010-05-25 Rigel Pharmaceuticals, Incorporated Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade
US7052843B2 (en) 2002-10-08 2006-05-30 New York University Transcription-based assay for identification of post-translational modification and its application in proteomics
US7312197B2 (en) * 2003-02-24 2007-12-25 University Of Maryland, Baltimore Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
US20070122807A1 (en) * 2003-04-03 2007-05-31 Proteologics, Inc. Posh polypeptides, complexes and related methods
WO2005000876A2 (en) * 2003-06-27 2005-01-06 Proteologics, Inc. Ring finger family proteins and uses related thereto
US7132234B2 (en) * 2003-10-28 2006-11-07 Rigel Pharmaceuticals, Inc. Methods and compositions for the identification of anti-poxvirus agents
EP1689850A4 (de) * 2003-11-10 2008-02-13 Rigel Pharmaceuticals Inc Hemmung der retrovirusreplikation über die modulation der wirtszellenubiquitylierung
EP1595945A1 (de) * 2004-05-14 2005-11-16 Boehringer Ingelheim International GmbH Screeningverfahren zur Identifizierung von Verbindungen, die die Wirkung von Myc inhibieren können.
AU2005295517A1 (en) * 2004-10-15 2006-04-27 Signal Pharmaceuticals, Llc P27 ubiquitination assay and methods of use
EP2482075A1 (de) 2004-12-01 2012-08-01 Proteologics, Ltd Ubiquitin-Ligase-Assays und verwandte Reagenzien
EP1838350B1 (de) 2005-01-20 2014-08-20 Ryboquin Company Limited Modulatoren für itch-ubiquitinase-aktivität
WO2006094293A2 (en) * 2005-03-03 2006-09-08 President And Fellows Of Harvard College Slim compositions and methods of use thereof
US20070060537A1 (en) * 2005-04-28 2007-03-15 Proteologics, Inc. Methods and compositions for inhibiting viral infections
DE602006019423D1 (de) * 2005-06-02 2011-02-17 Univ North Carolina Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase
KR100877824B1 (ko) * 2005-11-11 2009-01-12 한국생명공학연구원 Ｅ2ｅｐｆ ｕｃｐ-ｖｈｌ 상호작용 및 그 용도
US9066976B2 (en) 2005-11-11 2015-06-30 Korea Research Institute Of Bioscience And Biotechnology Method for therapeutic angiogenesis
WO2008042826A2 (en) * 2006-09-29 2008-04-10 University Of Maryland, Baltimore Use of omentin 1 and omentin 2 in the diagnosis and treatment of disease
CA2672565A1 (en) 2006-12-14 2008-06-19 Daiichi Sankyo Company, Limited Imidazothiazole derivatives
WO2008106087A1 (en) * 2007-02-28 2008-09-04 The Brigham And Women's Hospital, Inc. Compositions and methods for identifying factors affecting protein stability
US7892772B2 (en) * 2007-03-12 2011-02-22 Iti Scotland Limited Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins
MX344555B (es) 2007-05-08 2016-12-20 Hunter Douglas Ind Switzerland Sistema de color multivariado con aplicacion de textura.
AU2008297099A1 (en) 2007-09-14 2009-03-19 Basf Plant Science Gmbh Plants having increased yield-related traits and a method for making the same
FR2924721B1 (fr) * 2007-12-10 2010-02-26 Cytomics Systems Procede de criblage d'agents modulant l'activite de l'ubiquitine ligase mdm2 et moyens destines a la mise en oeuvre dudit procede
US20090269731A1 (en) * 2008-04-29 2009-10-29 Burnham Institute For Medical Research E3-independent ubiquitinylation assay
CN102282162B (zh) * 2008-04-29 2016-01-20 康奈尔大学 用于增强dna修复的物质和组合物及使用方法
WO2009151069A1 (ja) 2008-06-12 2009-12-17 第一三共株式会社 ４，７－ジアザスピロ［２．５］オクタン環構造を有するイミダゾチアゾール誘導体
US20110143958A1 (en) * 2008-07-25 2011-06-16 Jeffrey Gordon Marblestone Methods of Identifying Modulators of Ubiquitin Ligases
US8273540B2 (en) * 2008-10-09 2012-09-25 The Penn State Research Foundation Methods and compositions relating to E3 ring-E2 fusion proteins
PL2380892T3 (pl) 2009-01-16 2014-08-29 Daiichi Sankyo Co Ltd Pochodna imidazotiazolowa mająca strukturę pierścienia proliny
WO2011060409A2 (en) * 2009-11-16 2011-05-19 The Johns Hopkins University Cullen 5 as a regulator of hsp90 clients: a new target for drug development
CN102791847B (zh) 2010-01-12 2015-01-21 阿赫姆生物系统公司 三阶段热对流装置及其用途
GB201006604D0 (en) 2010-04-20 2010-06-02 Iti Scotland Ltd Ubiquitination assay
GB201007185D0 (en) 2010-04-29 2010-06-09 Iti Scotland Ltd Ubiquitination assay
US20130143251A1 (en) * 2010-06-01 2013-06-06 Ben-Gurion University Of The Negev Research And Development Authority Expeditious synthesis of ubiquitinated peptide conjugates
US9383367B1 (en) 2010-12-07 2016-07-05 Chunli Liu Methods of detecting conjugation site-specific and hidden epitope/antigen
HUE038714T2 (hu) 2011-03-10 2018-11-28 Daiichi Sankyo Co Ltd Dispiropirrolidin származék
WO2013042120A2 (en) 2011-09-19 2013-03-28 Proteologics Ltd Synthetic ubiquitins and use thereof in drug screening assays
RU2666530C2 (ru) * 2012-01-12 2018-09-11 Йейл Юниверсити Соединения и способы усиления деградации белков-мишеней и других полипептидов с помощью е3 убиквитин лигазы
EP2805281A4 (de) * 2012-01-18 2015-09-09 Singular Bio Inc Verfahren zur abbildung von strichcodierten molekülen zur erkennung von strukturvariationen und sequenzierungen
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
GB201311888D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201311891D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compound
US20160282354A1 (en) 2013-11-08 2016-09-29 The Broad Institute, Inc. Compositions and methods for selecting a treatment for b-cell neoplasias
US10071164B2 (en) 2014-08-11 2018-09-11 Yale University Estrogen-related receptor alpha based protac compounds and associated methods of use
US11261466B2 (en) 2015-03-02 2022-03-01 Sinai Health System Homologous recombination factors
WO2017044793A1 (en) 2015-09-11 2017-03-16 The Brigham And Women's Hospital, Inc. Methods of characterizing resistance to modulators of cereblon
MX2018005340A (es) 2015-11-02 2018-05-17 Univ Yale Proteolisis de direccionamiento a compuestos de quimera y metodos de preparacion y uso de los mismos.
US11604186B2 (en) * 2018-10-17 2023-03-14 Molecular Devices (Austria) GmbH Real time western blot assays utilizing fluorescence resonance energy transfer (FRET)
CN111208243B (zh) * 2018-11-21 2022-05-17 中国科学院大连化学物理研究所 一种基于阴离子交换色谱柱的sumo化肽段的富集方法
WO2022187342A1 (en) * 2021-03-02 2022-09-09 The Board Of Regents Of The University Of Texas System Methods and compositions for detecting protein targets
WO2023096721A1 (en) * 2021-11-23 2023-06-01 Board Of Regents, The University Of Texas System Fret-active e2-ubl conjugates and uses thereof

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
GB9214857D0 (en) 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
US5384255A (en) * 1993-06-21 1995-01-24 Rappaport Family Institute For Research In The Medical Sciences Ubiquitin carrier enzyme E2-F1, purification, production, and use
US5744343A (en) * 1994-01-04 1998-04-28 Mitotix, Inc. Ubiquitin conjugating enzymes
DE69517010T2 (de) * 1994-01-04 2000-12-21 Mitotix Inc Ubiquitin-konjugierende enzyme
US5952481A (en) * 1994-03-31 1999-09-14 The University Of Leeds DNA encoding ubiquitin conjugating enzymes
US6127158A (en) * 1994-12-07 2000-10-03 President And Fellows Of Harvard College Ubiquitin conjugating enzymes
US5726025A (en) * 1995-04-20 1998-03-10 President And Fellows Of Harvard College Assay and reagents for detecting inhibitors of ubiquitin-dependent degradation of cell cycle regulatory proteins
US6001619A (en) * 1995-10-04 1999-12-14 Cold Spring Harbor Laboratory Ubiquitin ligases, and uses related thereto
US5861249A (en) 1996-04-23 1999-01-19 Cold Spring Harbor Laboratory Assays and reagents for identifying modulators of cdc25-mediated mitotic activation
US5840866A (en) * 1996-07-10 1998-11-24 Incyte Pharmaceuticals, Inc. Human ubiquitin-conjugating enzyme
EP0843008A1 (de) 1996-11-14 1998-05-20 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von dem Anaphase-fördernden Komplex
US5817494A (en) * 1997-05-21 1998-10-06 Incyte Pharmaceuticals, Inc. Ubiquitin conjugation proteins
US6060262A (en) * 1997-07-16 2000-05-09 Mitotix, Inc. Regulation of I Kappa B (IκB) degradation and methods and reagents related thereto
AU8555798A (en) 1997-08-01 1999-02-22 Genset 5' ests for secreted proteins expressed in muscle and other mesodermal tissues
ES2266693T3 (es) 1997-08-01 2007-03-01 Serono Genetics Institute S.A. Ests 5' para proteinas secretadas expresadas en varios tejidos.
AU9664598A (en) * 1997-09-23 1999-04-12 Incyte Pharmaceuticals, Inc. Human ubiquitin-conjugating enzymes
US6573094B1 (en) * 1997-10-16 2003-06-03 Baylor College Of Medicine F-box genes and proteins
US6426205B1 (en) 1997-10-24 2002-07-30 Mount Sinai Hospital Corporation Methods and compositions for modulating ubiquitin dependent proteolysis
US5968747A (en) * 1997-12-12 1999-10-19 Incyte Pharmaceuticals, Inc. Ubiquitin-like conjugating protein
JP2001526063A (ja) 1997-12-19 2001-12-18 ワーナー−ランバート・カンパニー Ｓａｇ：アポトーシス感受性遺伝子
GB9727277D0 (en) 1997-12-23 1998-02-25 Medical Res Council Assay
US6165731A (en) * 1998-01-22 2000-12-26 California Institute Of Technology Assay for the ubiquitination-promoting activity of human proteins
US5976849A (en) * 1998-02-05 1999-11-02 Zeneca Limited Human E3 ubiquitin protein ligase
US6413725B1 (en) 1998-08-07 2002-07-02 California Institute Of Technology Biochemical assay to monitor the ubiquitin ligase activities of cullins
AU2342900A (en) 1998-09-23 2000-05-01 Cleveland Clinic Foundation, The Novel interferon stimulated and repressed genes
AU1203000A (en) 1998-10-09 2000-05-01 President And Fellows Of Harvard College Targeted proteolysis by recruitment to ubiquitin protein ligases
US6306663B1 (en) * 1999-02-12 2001-10-23 Proteinex, Inc. Controlling protein levels in eucaryotic organisms
DE60029429T2 (de) 1999-02-25 2007-02-22 Cyclacel Ltd. Verfahren und zusammensetzungen zur überwachung der modifikation von natürlichen bindungspartnern
WO2000050445A1 (en) 1999-02-26 2000-08-31 Oklahoma Medical Research Foundation Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
EP1165787A2 (de) 1999-03-31 2002-01-02 The University of North Carolina at Chapel Hill Cullin regulatoren roc1 und roc2, dafür kodierende dna, und methoden zur ihrer verwendug
JP2001192152A (ja) 2000-01-11 2001-07-17 Fuji Photo Film Co Ltd 給紙マガジン
US6740495B1 (en) * 2000-04-03 2004-05-25 Rigel Pharmaceuticals, Inc. Ubiquitin ligase assay
AU2001268683A1 (en) 2000-06-22 2002-01-02 Mount Sinai School Of Medicine Modification of mdm2 activity
EP1167539A1 (de) 2000-06-29 2002-01-02 Boehringer Ingelheim International GmbH Verfahren zur Identifizierung von Verbindungen die das Anaphae-fördernde Komplex hemmen
US6526205B1 (en) * 2000-10-13 2003-02-25 Agilent Technologies, Inc. Method and apparatus for the passive alignment of optical components
DE10108263A1 (de) 2001-02-21 2002-09-05 Max Planck Gesellschaft Analyse von Modifizierungen und Demodifizierungen von Proteinen mit Ubiquitinverwandten Proteinen mittels FRET (Fluorescence Resonance Energy Transfer)

Also Published As

Publication number Publication date
US20020042083A1 (en) 2002-04-11
US20060105409A1 (en) 2006-05-18
US20090263831A1 (en) 2009-10-22
ES2296744T3 (es) 2008-05-01
WO2001075145A2 (en) 2001-10-11
AU2001251291A1 (en) 2001-10-15
US7781182B2 (en) 2010-08-24
DE60131262T2 (de) 2008-08-28
WO2001075145A3 (en) 2002-07-25
US20050032139A1 (en) 2005-02-10
JP2003529372A (ja) 2003-10-07
EP1268847B1 (de) 2007-11-07
EP1268847A2 (de) 2003-01-02
US7022493B2 (en) 2006-04-04
US6740495B1 (en) 2004-05-25
US6737244B2 (en) 2004-05-18
DK1268847T3 (da) 2008-03-10
JP4095805B2 (ja) 2008-06-04
DE60131262D1 (en) 2007-12-20

Similar Documents

Publication Publication Date Title
ATE377654T1 (de) Ubiquitin-ligase-assay
PT1086076E (pt) Inibidores de sulfonamida de aspartil protease
BR0317715A (pt) Composições e processos de uso de collajolie
MA28985B1 (fr) Analogues de loxapine et methodes d'utilisation
AU2003265859A8 (en) Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents
HK1102197A1 (en) Hif prolyl hydroxylase activity assay
BRPI0515079A (pt) marcadores imobilizados e métodos de detecção de prions conformacionalmente alterados
AU2003216541A1 (en) Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
DE60029413D1 (de) Enzymatische messung von mycophenolsäure
FR2816843B1 (fr) Inhibiteurs de l'enzyme 5 alpha-reductase
WO2000068414A3 (en) Whole cell assay for cathepsin k
DK1147420T3 (da) Urintrypsininhibitor til diagnosticering af AIDS
WO2002093177A3 (en) Assays for identifying modulators of rhomboid polypeptides
DK1095032T3 (da) Hidtil ukendte fluorescerende CYP2D-assayreagenser
ATE389029T1 (de) Protease assay zur kontrolle medikamentöser therapie
DE69716897D1 (de) Assay zur messung von peroxidaseaktivität
DE50105492D1 (de) Hefestamm zur prüfung der geno- und zytotoxizität komplexer umweltkontaminationen
ES2256224T3 (es) Deteccion de proteasas o de peptidasas por fluorescencia.
DE69936359D1 (de) Reagenz zum Assay von Amylase-Isoenzymaktivität
ATE360704T1 (de) Neuartige peroxidasesubstrate und ihre anwendung in katalysierten reporterbindungsassays
DE60140550D1 (de) Immobilisierte phosphatidsäuresonde
DE60324259D1 (de) Reagens zur messung der aktivität von alaninaminotransferase
BRPI0512806A (pt) métodos envolvendo sintase de prostaglandina e2 microssomal
UY27974A1 (es) Derivados de sulfonamida
ATE346159T1 (de) Enzymatische spaltung von selektiven modulatoren des östrogenrezeptors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1268847

Country of ref document: EP